KCx Integrates Proprietary Data into FlexTrade’s AI Assistant, FlxAI
FlexTrade Systems, a global leader in multi-asset execution and order management systems, and Kepler Cheuvreux, a leading independent European financial services company through its KCx execution services, today announced the availability of KCx’s sophisticated analytical suite directly from FlexTrade’s AI assistant, FlxAI, to deliver intelligent, high-value insights into client workflows.
With rapid advancements in AI, large language models are reshaping how financial firms interact with data. Trading desks are increasingly embracing conversational AI to streamline decision-making and extract actionable insights faster than ever before. In response to market drivers, the new workflow has been developed as part of a collaborative initiative between KCx’s and FlexTrade’s teams.
Through the new collaboration, users of FlxAI, which is seamlessly embedded in FlexTrade's FlexONE OEMS and FlexTRADER EMS solutions, can actively query KCx liquidity drivers through natural language commands, such as "What's the anticipated closing volume according to KCx?" or "What does KCx think the volatility will be today?" FlxAI translates these requests into API commands, which are passed to KCx. KCx then returns the result, derived from vast streams of structured data — timestamps, prices, venues, order types — which FlxAI translates and presents to the end user within the order blotter as rich, human-readable narratives. These narratives explain factors such as slippage drivers, venue performance, and hidden cost patterns. Additionally, using AI, KCx’s analytics continuously learns from evolving market conditions, transforming the analytics feedback in real-time.
Further development from KCx will see their own AI chat agent launch, delivering additional proprietary data points and working order content to users directly. Through agent-to-agent communication, FlxAI will extend to this AI agent to provide answers to user questions determined to be directed to KCx.
Chris McConville, Global Head of Execution Services and Trading at KCx said: “Built on the foundation of our robust API Analytical Suite offering, this workflow integration represents a major step forward. KCx is introducing this new capability through FlexTrade, which aligns with our mission to provide accessible, high-value insights directly into our clients' workflows. Rather than only focusing on AI-driven execution algorithms, our priority is to enhance workflow efficiency — improving decision support, reducing manual processes, and simplifying interactions with complex data. This enables traders and portfolio managers to focus on more strategic, high-value tasks.”
Andy Mahoney, Managing Director, EMEA at FlexTrade, stated: “Our existing integration with KCx’s analytic suite has proved popular with clients looking to source high-quality, adaptive market intelligence. Integrating the KCx data source into FlxAI was a natural step to extend the coverage to third-party data, which is relevant, useful, and timely to users. As the sell-side finds new and unique ways to deliver content to clients, we aim to provide a seamless interface to access all services available. With FlxAI, connected to an abundance of data sources and other AI agents, this will ensure interaction is completely natural.”
Anvar Karimson, Chief Technology Officer, Kepler Cheuvreux, noted:“This innovative integration marks a significant technological advancement in delivering intelligence when traders need it most. By connecting KCx analytics with FlxAI, we're transforming how insights flow through decision workflows. Natural language interaction elegantly removes barriers between complex analysis and trading decisions. This reflects our core belief that sophisticated technology should feel intuitive while enhancing how clients interact with markets.”
KCx and FlexTrade will demonstrate this innovation at TradeTech Europe, May 13 - 15. The FlexTrade team will be in Track C during the roundtable sessions at the Buy-Side Innovation Day on May 13. Additionally, the innovation will be showcased at Booth 36 with the FlexTrade team or Booth 58 with the KCx team during the Main Conference on May 14 and 15.
About Kepler Cheuvreux:
Kepler Cheuvreux is a leading independent European financial services company that specialises in Research, Execution (KCx), Fixed Income and Credit, Structured Solutions, Corporate Finance, and Asset Management.
The group employs around 600 people and is present in 14 major financial centres in Europe, the US, and the Middle East: Amsterdam, Brussels, Dubai, Frankfurt, Geneva, London, Madrid, Milan, New York, Oslo, Paris, Stockholm, Vienna, and Zurich.
About FlexTrade:
FlexTrade Systems provides customized multi-asset execution and order management trading solutions for buy- and sell-side financial institutions. Through deep client partnerships with some of the world's largest, most complex, and demanding capital markets firms, we develop the flexible tools, technology, and innovation that give our clients a competitive edge. Our globally distributed engineering teams focus on adaptable technology and open architecture to develop highly sophisticated trading solutions that can automate and scale with your business strategies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250512589499/en/
Contacts
Iain Smith
Iain.Smith@FlexTrade.com
O: +44 20 3757 9311
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press Release
Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly three years, while adding a seasoned in-country team spanning operations, support, sales, finance, and leadership to enable rapid integration and future growth. The E
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press Release
Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which translate into thinner, more discreet and comfortable products. Its high compression capability enables s
SES Acknowledges Moody’s Rating Action and Reiterates Deleveraging Commitments17.12.2025 21:36:00 CET | Press Release
SES S.A. (“SES” or the “Company”), a leading space solutions company, acknowledges the credit rating action announced by Moody’s Investor Service today, which follows the release of SES’ Q3 2025 results and Intelsat integration update. SES management reiterates that the Company continues to execute on its strategy with a clear plan to strengthen its key credit metrics over time. Consistent with this plan, it remains management’s intention to de-lever and return to credit metrics that are commensurate with investment grade, with a policy objective of reducing adjusted net leverage1 to at least 3.0x or below. Today’s rating action does not change the Company’s ability to operate its business, serve customers, or execute its strategic plan. SES maintains a balanced weighted average debt maturity profile of approximately five years, and the rating action from Moody’s is not expected to have a material impact on the interest payable under the Company’s existing debt facilities. SES also ben
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom